Suven Life Sciences Cash Flow Annual

Trade
BSE: 530239 | NSE: SUVEN | ISIN: INE495B01038 | Sector: Biotechnology & Drugs
118.50 +1.05 (0.89%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line -106.08-118.27-122.00-77.47
Depreciation/ Depletion 5.825.833.563.52
Non- Cash Items 4.58-1.09-4.66-6.22
Changesin Working Capital 13.0710.38-4.45-15.85
Cashfrom Operating Activities -82.62-103.15-127.54-96.02
Other Investing Cash Flow Items Total 61.59-257.75-2.4662.15
Cashfrom Investing Activities 61.59-260.65-22.2355.84
Financing Cash Flow Items -0.16-0.26-0.40-0.82
Issuance( Retirement)of Debt Net -0.90-1.60-1.56-1.25
Cashfrom Financing Activities -1.05395.54145.6934.86
Net Changein Cash -22.0931.75-4.07-5.33
Cash Interest Paid 0.160.260.400.82
Cash Taxes Paid -6.181.100.521.15
Capital Expenditures --2.89-19.77-6.30
Issuance( Retirement)of Stock Net -397.40147.6436.92
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts